Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis

In this study we describe the immunogenicity results from a subset of older people (N = 5187) who participated in a Phase 3 randomized, observer-blinded trial of AS03-TIV versus TIV (Fluarix™) (ClinicalTrials.gov, NCT00753272). Participants received one dose of AS03-TIV or TIV in each study year and...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hum Vaccin Immunother
Autori principali: Ruiz-Palacios, Guillermo M., Leroux-Roels, Geert, Beran, Jiri, Devaster, Jeanne-Marie, Esen, Meral, Launay, Odile, McElhaney, Janet E., van Essen, Gerrit A., Benoit, Anne, Claeys, Carine, Dewé, Walthère, Durand, Christelle, Duval, Xavier, Falsey, Ann R., Feldman, Gregory, Galtier, Florence, Gervais, Pierre, Hwang, Shinn-Jang, McNeil, Shelly, Richardus, Jan Hendrik, Trofa, Andrew, Oostvogels, Lidia
Natura: Artigo
Lingua:Inglês
Pubblicazione: Taylor & Francis 2016
Soggetti:
Research Papers
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5215410/
https://ncbi.nlm.nih.gov/pubmed/27690762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2016.1219809
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi